Prevalence of dysautonomia in chronic musculoskeletal pain: a cross-sectional study

Clicks: 14
ID: 328701
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #265 of 339 articles by views in Lara D. Veeken

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 339 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Objectives There is substantial evidence that the autonomic nervous system plays a crucial role in pain modulation and chronicity, but the actual prevalence of dysautonomia in musculoskeletal conditions remains unknown. This study investigated the prevalence of dysautonomia in patients with Chronic Musculoskeletal Pain (CMP) compared to healthy controls, quantified the dysautonomia burden in inflammatory and non-inflammatory musculoskeletal conditions, and evaluated the associations between pain severity, psychological factors, and dysautonomia severity. Methods This cross-sectional study recruited patients with CMP between October 2024 and July 2025 along with healthy participants with similar age-sex distribution. Inclusion criteria were a clinician-confirmed musculoskeletal condition and pain duration >12 weeks. Assessments included the Composite Autonomic Symptom Score-31, the Brief Pain Inventory, and the Hospital Anxiety and Depression Scale. A COMPASS-31 score of 17 or higher was considered indicative of dysautonomia. Results Of 896 patients screened, 342 participated, along with 57 healthy controls. Dysautonomia was significantly more prevalent in CMP patients (74%) compared to controls (11%) (adjusted RR = 7.4, 95% CI 1.8-13.1, p = 0.010). Dysautonomia rates were similarly high in inflammatory (76%) and non-inflammatory (72%) conditions. Risk of dysautonomia increased with pain severity (RR 1.27 per point on BPI, 95% CI 1.08-1.45, p < 0.001), depression (RR 1.12 per HADS depression score, 95% CI 1.06-1.19, p < 0.001), and anxiety (RR 1.15 per HADS anxiety score, 95% CI 1.08-1.22, p < 0.001), adjusting for age and gender. Conclusion Dysautonomia is highly prevalent among patients with CMP irrespective of inflammatory status and is associated with pain severity, depression and anxiety. CMP patients should be assessed for dysautonomia as a potential contributor to symptom burden.
Reference Key
openalex_W7212330473 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors N.A. Almutairi, D.C. Greenwood, M. Sivan
Are you one of these authors? Claim your profile
Journal Lara D. Veeken
Year 2026
DOI
10.1093/rheumatology/keag511
URL
https://doi.org/10.1093/rheumatology/keag511
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.